Breast Cancer — SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)
Citation(s)
A Phase 2 Randomized, Multicenter Trial on Silibinin To Prevent Intracranial Recurrence After Gross-Total Resection of Single Brain Metastasis From Non-Small Cell Lung Cancer or Breast Cancer